Together, these strategies form a robust blueprint for achieving a favorable balance between therapeutic efficacy and biosafety
doi: 10.1056/NEJM199902113400603 24 TalaeiARafeeNRafeiFChehreiA
At 30 mg/ml concentration: 2.5 mg = 0.083 ml = 8.3 units on a 0.3 ml syringe
to conduct a multicenter retrospective cohort study to assess the association of GLP-1RAs with the risk of intestinal obstruction compared with non-GLP-1RA anti-diabetic medications including SGLT2 inhibitors, metformin, sulfonylureas (SU), thiazolidinediones (TZDs), dipeptidyl peptidase-4 (DPP-4) inhibitors, and insulins, across follow-up periods of 1, 3, and 5 years
Declines in mitochondrial function are a significant underlying cause of the energy drain associated with aging, and carnitine plays an essential role in increasing energy production